13 studies found for:    CYP27B1
Show Display Options
Rank Status Study
1 Completed
Has Results
Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism
Condition: Secondary Hyperparathyroidism
Intervention: Drug: Teriparatide
2 Completed
Has Results
Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease
Condition: End-Stage Renal Disease
Intervention: Drug: Cholecalciferol
3 Unknown  Supplementary Intake of Vitamin D During 12 Weeks Strength Training in Younger and Older People
Conditions: Muscle Strength;   Tendon Elasticity;   Muscle CSA;   Tendon CSA;   VDR Receptor
Intervention: Other: 12 weeks Strength exercise training
4 Recruiting Vitamin D Supplementation and Male Infertility: The CBG-study a Randomized Clinical Trial
Condition: Male Infertility
Interventions: Drug: Cholecalciferol and calcium;   Other: Placebo
5 Completed Serum 1,25-dihydroxyvitamin D Levels in Type 2 Diabetes Mellitus Patients With Different Levels of Albuminuria
Condition: Type 2 Diabetes Mellitus With Diabetic Nephropathy
6 Recruiting Evaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous Xanthomatosis
Condition: Cerebrotendinous Xanthomatosis (CTX)
Intervention: Biological: Blood tests
7 Completed
Has Results
Expanded Access Program for Maraviroc At Multiple Centers
Condition: Advanced HIV Infection
Intervention: Drug: maraviroc
8 Completed Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin
Conditions: HCV Coinfection;   HIV-1 Infection
Intervention: Drug: Boceprevir, Peg-interferon alfa 2b and Ribavirin
9 Completed The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the Bloodstream
Condition: Healthy Volunteers
Interventions: Drug: LY2409021;   Drug: Gemfibrozil;   Drug: Ketoconazole;   Drug: Clarithromycin
10 Unknown  Anti-inflammatory Agents and Cholesterol Metabolism
Condition: Osteoarthritis
11 Completed A Study to Determine the Absorption, Metabolism, and Routes of Excretion of (14C) Radiolabeled Ibrutinib in Healthy Male Participants
Condition: Healthy Participants
Intervention: Drug: Ibrutinib
12 Unknown  CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide
Conditions: Chemotherapeutic Agent Toxicity;   Sarcoma;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Genetic: gene expression analysis;   Genetic: polymorphism analysis;   Procedure: management of therapy complications
13 Terminated Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: PF-3512676 + Paclitaxel + Carboplatin;   Drug: Paclitaxel + Carboplatin

Indicates status has not been verified in more than two years